Literature DB >> 5556355

[The simultaneous use of rifampicin and other antitubercular agents with oral contraceptives].

D Reimers, A Jezek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5556355

Source DB:  PubMed          Journal:  Prax Pneumol        ISSN: 0032-7069


× No keyword cloud information.
  30 in total

Review 1.  Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans.

Authors:  G R Wilkinson
Journal:  J Pharmacokinet Biopharm       Date:  1996-10

2.  Serologic studies on the occurrence of specific rifampicin antibodies during continuous rifampicin treatment--its frequency and significance.

Authors:  R Kropp; M Krüpe; H Jungbluth
Journal:  Pneumonologie       Date:  1976-04-09

Review 3.  Adverse drug interactions.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2011

4.  Antituberculous therapy in pregnancy. Risks to the fetus.

Authors:  D J Scheinhorn; V A Angelillo
Journal:  West J Med       Date:  1977-09

Review 5.  Pharmacokinetic drug interactions with oral contraceptives.

Authors:  D J Back; M L Orme
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 6.  Antimicrobial drugs.

Authors:  Daniel E Becker
Journal:  Anesth Prog       Date:  2013

7.  Letter: Drugs affecting oral contraceptives.

Authors:  J P Mumford
Journal:  Br Med J       Date:  1974-05-11

Review 8.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

9.  No interaction between ciprofloxacin and an oral contraceptive.

Authors:  P C Scholten; R M Droppert; M G Zwinkels; H L Moesker; J J Nauta; I M Hoepelman
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

Review 10.  The pregnane X receptor: from bench to bedside.

Authors:  Xiaochao Ma; Jeffrey R Idle; Frank J Gonzalez
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-07       Impact factor: 4.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.